A Randomised, Open-Label Preliminary Study to Assess the Effects of Etanercept 50 mg Once Weekly for 24 Weeks and Etanercept 50 mg Twice Weekly for 12 Weeks Reducing to Etanercept 50 mg Once Weekly for 12 Weeks on Nail and Skin Symptoms in Patients With Nail Psoriasis and Plaque Psoriasis. - ND
An open-label, multicentre, supplementary and extension study of Etanercept in subjects with Ankylosing Spondylitis (AS)
A Multicenter, Parallel, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Moderate to Severe Plaque Psoriasis
100 Clinical Results associated with Wyeth Pharmaceuticals France SAS
0 Patents (Medical) associated with Wyeth Pharmaceuticals France SAS
100 Deals associated with Wyeth Pharmaceuticals France SAS
100 Translational Medicine associated with Wyeth Pharmaceuticals France SAS